Maravai LifeSciences Holdings (FRA:MAR) Long-Term Debt : €476.5 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Maravai LifeSciences Holdings Long-Term Debt?

Maravai LifeSciences Holdings's Long-Term Debt for the quarter that ended in Mar. 2024 was €476.5 Mil.

Maravai LifeSciences Holdings's quarterly Long-Term Debt declined from Sep. 2023 (€486.8 Mil) to Dec. 2023 (€475.7 Mil) but then increased from Dec. 2023 (€475.7 Mil) to Mar. 2024 (€476.5 Mil).

Maravai LifeSciences Holdings's annual Long-Term Debt increased from Dec. 2021 (€464.3 Mil) to Dec. 2022 (€492.8 Mil) but then declined from Dec. 2022 (€492.8 Mil) to Dec. 2023 (€475.7 Mil).

Maravai LifeSciences Holdings Long-Term Debt Historical Data

The historical data trend for Maravai LifeSciences Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maravai LifeSciences Holdings Long-Term Debt Chart

Maravai LifeSciences Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

301.31

434.52

464.26

492.77

475.65

Maravai LifeSciences Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															486.76	480.27	486.79	475.65	476.46

Maravai LifeSciences Holdings (FRA:MAR) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Maravai LifeSciences Holdings Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Maravai LifeSciences Holdings's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Maravai LifeSciences Holdings (FRA:MAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maravai LifeSciences Holdings Inc (FRA:MAR) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

MRVI:USA MRVI:Mexico MAR:Germany

Address

10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121

Website

https://www.maravai.com

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.